australiannationalreview--2020-07-30--Facebook, Google/YouTube, Twitter Censor Viral Video of Doctors’ Capitol Hill Coronavirus Press Conf

Facebook has removed a video posted by Breitbart News earlier today , which was the top-performing Facebook post in the world Monday afternoon , of a press conference in D.C. held by the group America ’ s Frontline Doctors and organized and sponsored by the Tea Party Patriots .
The press conference featured Rep. Ralph Norman ( R-SC ) and frontline doctors sharing their views and opinions on coronavirus and the medical response to the pandemic .
YouTube ( which is owned by Google ) and Twitter subsequently removed footage of the press conference as well .
The video accumulated @ @ @ @ @ @ @ hours it was hosted on Facebook , with over 185,000 concurrent viewers .
The livestream had accumulated over 17 million views by the time of its censorship by Facebook .
In terms of viral velocity , the post was beating content from many other prominent accounts on Facebook today , including Hillary Clinton , Rev .
Franklin Graham , and Kim Kardashian .
The event , hosted by the organization America ’ s Frontline Doctors , a group founded by Dr. Simone Gold , a board-certified physician and attorney , and made up @ @ @ @ @ @ @ address what the group calls a “ massive disinformation campaign ” about the coronavirus .
Norman also spoke at the event .
“ If Americans continue to let so-called experts and media personalities make their decisions , the great American experiment of a Constitutional Republic with Representative Democracy , will cease , ” reads the event ’ s information page .
The event was organized and sponsored by the Tea Party Patriots .
“ We ’ ve removed this video for sharing false information about cures and treatments for COVID-19 , ” a @ @ @ @ @ @ @ told Breitbart News .
The company did not specify what portion of the video it ruled to be “ false information , ” who it consulted to make that ruling , and on what basis it was made .
Stone replied to New York Times tech columnist Kevin Roose on Twitter regarding the video : Stone then added that the platform would direct users who had interacted with the post to information on “ myths debunked by the WHO.
” Facebook ’ s decision to censor the livestream was quickly followed by YouTube @ @ @ @ @ @ @ video had over 80,000 views on YouTube prior to its removal .
Following Facebook and YouTube ’ s removal of the video , Twitter followed suit , removing Breitbart News ’ s Periscope livestream of the press conference .
Jack Dorsey ’ s platform also then limited the Breitbart News official account , indicating that tweets containing links to multiple stories about the press conference violate the platform ’ s COVID-19 policies .

Facebook, Google/YouTube, Twitter Censor Viral Video of Doctors’ Capitol Hill Coronavirus Press Conference.
By ALLUM BOKHARI
Facebook has removed a video posted by Breitbart News earlier today, which was the top-performing Facebook post in the world Monday afternoon, of a press conference in D.C. held by the group America’s Frontline Doctors and organized and sponsored by the Tea Party Patriots. The press conference featured Rep. Ralph Norman (R-SC) and frontline doctors sharing their views and opinions on coronavirus and the medical response to the pandemic. YouTube (which is owned by Google) and Twitter subsequently removed footage of the press conference as well.
The video accumulated over 17 million views during the eight hours it was hosted on Facebook, with over 185,000 concurrent viewers.
The livestream had accumulated over 17 million views by the time of its censorship by Facebook.
In terms of viral velocity, the post was beating content from many other prominent accounts on Facebook today, including Hillary Clinton, Rev. Franklin Graham, and Kim Kardashian.
The event, hosted by the organization America’s Frontline Doctors, a group founded by Dr. Simone Gold, a board-certified physician and attorney, and made up of medical doctors, came together to address what the group calls a “massive disinformation campaign” about the coronavirus. Norman also spoke at the event.
“If Americans continue to let so-called experts and media personalities make their decisions, the great American experiment of a Constitutional Republic with Representative Democracy, will cease,” reads the event’s information page.
The event was organized and sponsored by the Tea Party Patriots.
“We’ve removed this video for sharing false information about cures and treatments for COVID-19,” a Facebook company spokesman, Andy Stone, told Breitbart News. The company did not specify what portion of the video it ruled to be “false information,” who it consulted to make that ruling, and on what basis it was made.
Stone replied to New York Times tech columnist Kevin Roose on Twitter regarding the video:
Stone then added that the platform would direct users who had interacted with the post to information on “myths debunked by the WHO.”
Facebook’s decision to censor the livestream was quickly followed by YouTube, the Google-owned video-sharing platform. The video had over 80,000 views on YouTube prior to its removal.
Following Facebook and YouTube’s removal of the video, Twitter followed suit, removing Breitbart News’s Periscope livestream of the press conference. Jack Dorsey’s platform also then limited the Breitbart News official account, indicating that tweets containing links to multiple stories about the press conference violate the platform’s COVID-19 policies.


australiannationalreview--2020-07-30--AN INCONVENIENT COVID TRUTH

AN INCONVENIENT COVID TRUTH

Australian National Review ’ s community of readers and following is stronger than ever .
However , advertising revenues across @ @ @ @ @ especially without a paywall .
Will you help us remain a force for good and @ @ @ @ @ government and industry ?
We want to continue on our mission to enforce a free @ @ @ @ @ day and age where mainstream media and big corporations are going all out to suppress @ @ @ @ @ without supporters donations we can ’ t fund ANR .
By supporting The Australian National @ @ @ @ @ can afford , you can help us ensure that everyone is informed of the truth @ @ @ @ @ press for years to come .

URGENT: JUST 7 DAYS REMAIN TO HELP SAVE INDEPENDENT MEDIA & ANR, SO LET'S CUT THE BS & GET TO THE POINT - WE WILL BE FORCED LAY OFF STAFF & REDUCE OPERATIONS UNLESS WE ARE FULLY FUNDED WITHIN THE NEXT 2 WEEKS - Sadly, less than 0.5% of readers currently donate or subscribe to us But YOU can easily change that. Imagine the impact we'd make if 3 in 10 readers supported us today. To start with we’d remove this annoying banner as we could fight for a full year...


australiannationalreview--2020-07-30--5G Radiation Linked To Coronavirus Infection, New Study Suggests

A new paper published in the Journal of Biological Regulators & Homeostatic Agents posits there may be a unique , causally connected relationship between 5G millimeter wave exposure and coronavirus — an idea which , though widely discussed early on in the global COVID crisis , was eventually dismissed as “ conspiracy theory ” by the mainstream media and government officials , resulting in widespread censorship on social media platforms The new study , titled “ 5G Technology and induction of coronavirus in skin cells , ” authored by an international collaboration of scientists from Italy , the U.S. and @ @ @ @ @ @ @ be absorbed by dermatologic cells that act like antennas , * thereby transferring its effects to other cells , including activating DNA-based biosynthetic processes within the nucleus of the cell , possibly resulting in the de novo synthesis of coronaviruses in biological cells .
The authors describe how this may work as follows : “ DNA is built from charged electrons and atoms and has an inductor-like structure .
This structure could be divided into linear , toroid and round inductors .
Inductors interact with external electromagnetic waves , move and produce some @ @ @ @ @ @ @ shapes of these waves are similar to shapes of hexagonal and pentagonal bases of their DNA source .
These waves produce some holes in liquids within the nucleus .
To fill these holes , some extra hexagonal and pentagonal bases are produced .
These bases could join to each other and form virus-like structures such as Coronavirus .
To produce these viruses within a cell , it is necessary that the wavelength of external waves be shorter than the size of the cell .
Thus 5G millimeter waves could be good candidates for @ @ @ @ @ @ @ Coronaviruses ( COVID-19 ) within cells.
” The idea that one of the causes of illness associated with the coronavirus crisis derives from non-native electromagnetic radiation exposure , including from 5G millimeter waves , was proposed by Dr. Thomas Cowan in the highly controversial presentation below .
This has been labeled as “ false and harmful ” information on a variety of social media and global mainstream media platforms .
According to Cowan , 5G millimeter waves may induce cell damage that results in the excretion of cellular contents , which include nucleic @ @ @ @ @ @ @ within cells as natural forms of intercellular communication ) .
This debris , which he describes as part of the detoxification of the damaged cells ( “ cellular pooping ” ) , may be mistakenly identified as exogenous viruses such as coronavirus and may result in false positives on RT-PCR tests , which are notoriously ineffective at positively distinguishing specific strains of viruses and identifying them with any certainty .
While this idea differs slightly from the one proposed by the study authors , they overlap in significant ways .
In both explanations @ @ @ @ @ @ @ that are identified as being caused by “ COVID virus.
” Whether or not there is a de novo synthesis of coronaviruses as a result of 5G radiation exposure , or whether or not the damage to the cell produces debris containing COVID virus like nucleic acid , remains to be determined .
But in both scenarios , what is perceived as a COVID illness from the outside in may in fact be the byproduct of cellular changes resulting from EMF exposure and not an exogenous viral infection , as commonly assumed .
@ @ @ @ @ @ @ topic and discovered that what the global mainstream medical establishment and media are identifying as “ COVID-19 ” is likely our own exosomes being secreted by either healthy or damaged cells .
I highly recommend viewing his presentation below , and you can obtain more presentations of this kind in section two of QuestioningCovid.com , titled , Questioning Germ Theory , Contagion and Viral Testing .
My take on it , which I explore in the video below — “ COVID-19 — is it really about a virus ?
” — is that @ @ @ @ @ @ @ bodies simulate infectious processes , but rather than being simply a sign of pathology and imminent morbidity and mortality are designed to support the collective health of a group of individuals or species , or even between species .
In this view , what is commonly understood to be infection and contagion is actually a surface misunderstanding of a process of horizontal information exchange designed to facilitate enhanced detoxification , xenohormesis and the activation of resiliency pathways within a species , and is the very origin of what is known as “ herd @ @ @ @ @ @ @ up an important topic that has been all but suppressed and censored today , namely , that health problems associated with infections such as coronavirus involve a wide range of factors , including foremost the role of the so-called “ bioterrain ” of the cell in determining susceptibility to infection and illness .
Viruses do not exist in a vacuum and don ’ t simply attack helpless bodies .
When the cellular terrain is healthy and resilient infections tend not to take hold , or even have effects that confer lasting health benefits @ @ @ @ @ @ @ human microbiome ( and the total set of viruses or viral-like components of the microbiome known as the human virome ) reveals that classical germ theory is bankrupt , and that what we once believed were invisible viral threats “ out there ” are surprisingly similar , if not identical , to endogenous viral-like elements within our cells known as exosomes , and often can not be distinguished from them .
For example , the widespread use of RT-PCR tests to identify “ COVID ” may simply be identifying our bodies ’ own @ @ @ @ @ @ @ generating “ false positives , ” which justify the continual implementation of allopathic approaches that result in profound iatrogenic damage to the body , falsely described as “ caused by COVID.
” I highly recommend that those interested in understanding the true nature of viruses and their indispensable role in establishing immunological self-tolerance , homeostasis , and ultimately health , watch distinguished National Institutes of Health speaker and virome expert Dr. Herbert Virgin ’ s presentation .

5G Radiation Linked To Coronavirus Infection, New Study Suggests.
A new paper published in the Journal of Biological Regulators & Homeostatic Agents posits there may be a unique, causally connected relationship between 5G millimeter wave exposure and coronavirus — an idea which, though widely discussed early on in the global COVID crisis, was eventually dismissed as “conspiracy theory” by the mainstream media and government officials, resulting in widespread censorship on social media platforms
The new study, titled “5G Technology and induction of coronavirus in skin cells,” authored by an international collaboration of scientists from Italy, the U.S. and Russia, suggests that 5G radiation may be absorbed by dermatologic cells that act like antennas,* thereby transferring its effects to other cells, including activating DNA-based biosynthetic processes within the nucleus of the cell, possibly resulting in the de novo synthesis of coronaviruses in biological cells.
The authors describe how this may work as follows:
“DNA is built from charged electrons and atoms and has an inductor-like structure. This structure could be divided into linear, toroid and round inductors. Inductors interact with external electromagnetic waves, move and produce some extra waves within the cells. The shapes of these waves are similar to shapes of hexagonal and pentagonal bases of their DNA source.
These waves produce some holes in liquids within the nucleus. To fill these holes, some extra hexagonal and pentagonal bases are produced. These bases could join to each other and form virus-like structures such as Coronavirus.
To produce these viruses within a cell, it is necessary that the wavelength of external waves be shorter than the size of the cell. Thus 5G millimeter waves could be good candidates for applying in constructing virus-like structures such as Coronaviruses (COVID-19) within cells.”
The idea that one of the causes of illness associated with the coronavirus crisis derives from non-native electromagnetic radiation exposure, including from 5G millimeter waves, was proposed by Dr. Thomas Cowan in the highly controversial presentation below. This has been labeled as “false and harmful” information on a variety of social media and global mainstream media platforms.
According to Cowan, 5G millimeter waves may induce cell damage that results in the excretion of cellular contents, which include nucleic acids and exosomes (virus-like nanoparticles produced within cells as natural forms of intercellular communication).
This debris, which he describes as part of the detoxification of the damaged cells (“cellular pooping”), may be mistakenly identified as exogenous viruses such as coronavirus and may result in false positives on RT-PCR tests, which are notoriously ineffective at positively distinguishing specific strains of viruses and identifying them with any certainty.
While this idea differs slightly from the one proposed by the study authors, they overlap in significant ways. In both explanations, 5G associated radiation induces cell changes that are identified as being caused by “COVID virus.”
Whether or not there is a de novo synthesis of coronaviruses as a result of 5G radiation exposure, or whether or not the damage to the cell produces debris containing COVID virus like nucleic acid, remains to be determined. But in both scenarios, what is perceived as a COVID illness from the outside in may in fact be the byproduct of cellular changes resulting from EMF exposure and not an exogenous viral infection, as commonly assumed.
Dr. Andrew Kaufman has also explored this topic and discovered that what the global mainstream medical establishment and media are identifying as “COVID-19” is likely our own exosomes being secreted by either healthy or damaged cells.
I highly recommend viewing his presentation below, and you can obtain more presentations of this kind in section two of QuestioningCovid.com, titled, Questioning Germ Theory, Contagion and Viral Testing.
My take on it, which I explore in the video below — “COVID-19 — is it really about a virus?” — is that exosomal processes within the body and between bodies simulate infectious processes, but rather than being simply a sign of pathology and imminent morbidity and mortality are designed to support the collective health of a group of individuals or species, or even between species.
In this view, what is commonly understood to be infection and contagion is actually a surface misunderstanding of a process of horizontal information exchange designed to facilitate enhanced detoxification, xenohormesis and the activation of resiliency pathways within a species, and is the very origin of what is known as “herd immunity.”
This latest paper opens back up an important topic that has been all but suppressed and censored today, namely, that health problems associated with infections such as coronavirus involve a wide range of factors, including foremost the role of the so-called “bioterrain” of the cell in determining susceptibility to infection and illness.
Viruses do not exist in a vacuum and don’t simply attack helpless bodies. When the cellular terrain is healthy and resilient infections tend not to take hold, or even have effects that confer lasting health benefits.
Moreover, the discovery of the human microbiome (and the total set of viruses or viral-like components of the microbiome known as the human virome) reveals that classical germ theory is bankrupt, and that what we once believed were invisible viral threats “out there” are surprisingly similar, if not identical, to endogenous viral-like elements within our cells known as exosomes, and often cannot be distinguished from them.
For example, the widespread use of RT-PCR tests to identify “COVID” may simply be identifying our bodies’ own viral or exosomal contents, and thereby generating “false positives,” which justify the continual implementation of allopathic approaches that result in profound iatrogenic damage to the body, falsely described as “caused by COVID.”
I highly recommend that those interested in understanding the true nature of viruses and their indispensable role in establishing immunological self-tolerance, homeostasis, and ultimately health, watch distinguished National Institutes of Health speaker and virome expert Dr. Herbert Virgin’s presentation.


australiannationalreview--2020-07-31--Doctors highlighting the fraud of waiting for a vaccine for Coronavirus

Doctors highlighting the fraud of waiting for a vaccine for Coronavirus .
Vaccines are the agenda .
They DO NOT @ @ @ @ @


australiannationalreview--2020-07-31--CDC Director Says Students Are Experiencing More Suicides and Overdoses than COVID Deaths

CDC Director Says Students Are Experiencing More Suicides and Overdoses than COVID Deaths .
Center for Disease Control Director Robert Redfield said in a Buck Institute webinar that suicides and drug overdoses have surpassed the death rate for COVID-19 among high school students .
Redfield argued that lockdowns and lack of public schooling constituted a disproportionally negative impact on young peoples ’ mental health .
“ But there has been another cost that we ’ ve seen , particularly in high schools , ” Redfield said .
“ We ’ re seeing , sadly , far greater suicides now than @ @ @ @ @ @ @ ’ re seeing far greater deaths from drug overdose that are above excess that we had as background than we are seeing the deaths from COVID .
So this is why I keep coming back for the overall social being of individuals , is let ’ s all work together and find out how we can find common ground to get these schools open in a way that people are comfortable and their safe.
” Roughly 146,000 people have died from COVID or COVID-related causes in the U.S. , according to CDC data @ @ @ @ @ @ @ records 48,000 deaths from suicide and at least 1.4 million attempts in 2018 .
In 2019 , almost 71,000 people died from drug overdoses .
Where Redfield obtained his data is unknown , although a doctor at John Muir Medical Center in Walnut Creek , CA claimed the facility has “ seen a year ’ s worth of suicide attempts in the last four weeks.
” He did not say how many deaths occurred , or whether the statement was exaggerated for emphasis .
“ What I have seen recently , I have @ @ @ @ @ @ @ .
“ I have never seen so much intentional injury , ” said a nurse from the same hospital .
And while health authorities will not have verified data regarding suicides and drug overdoses in 2020 for two more years , local reporting indicates that suicide fatalities have increased year-on-year .
According to the American Medical Association , “ More than 35 states have reported increases in opioid-related mortality as well as ongoing concerns for those with a mental illness or substance use disorder in counties and other areas within the state.
” @ @ @ @ @ @ @ suicides have been recorded , just one below the yearly average .
Colorado on the whole recorded a 40 percent decrease in suicides in March and April , but the number of calls to Colorado Crisis Services increased 48 percent .
The Chicago Sun-Times looked specifically at black populations .
In Cook County , Illinois , the number of suicide deaths is already higher than for all of 2019 .
In Yakima County , Washington , the suicide rate has risen 30 percent , according to the county coroner .
Between March 15 @ @ @ @ @ @ @ commited suicide in Queens , New York than did between January 1 and April 29 the year prior .
The Pima County Health Department in Arizona has recorded an uptick in suicide rates as well .
Ulster County reported a significant increase in both suicides and drug overdoses , both fatal and non-fatal .
Historical trends give reason to believe the suicide rate may rise due to extenuating circumstances caused by COVID-19 , including unemployment and social isolation .
For example , in the year after the Great Recession in 2008 , the @ @ @ @ @ @ @ than expected .
While the rate didn ’ t ’ “ skyrocket , ” as some have predicted it will this year , the coronavirus pandemic and economic shutdown has dealt a worse blow to the U.S. psyche .
Thirty to 40 million jobs have been lost to the economic shutdown , compared to 2.6 million in 2008 .
Editor ’ s Note : This piece has been updated to clarify that the CDC director was referring specifically to high school students when discussing the rate of suicides vs. COVID deaths .

CDC Director Says Students Are Experiencing More Suicides and Overdoses than COVID Deaths.
By Micaela Burrow
Center for Disease Control Director Robert Redfield said in a Buck Institute webinar that suicides and drug overdoses have surpassed the death rate for COVID-19 among high school students. Redfield argued that lockdowns and lack of public schooling constituted a disproportionally negative impact on young peoples’ mental health.
“But there has been another cost that we’ve seen, particularly in high schools,” Redfield said. “We’re seeing, sadly, far greater suicides now than we are deaths from COVID. We’re seeing far greater deaths from drug overdose that are above excess that we had as background than we are seeing the deaths from COVID. So this is why I keep coming back for the overall social being of individuals, is let’s all work together and find out how we can find common ground to get these schools open in a way that people are comfortable and their safe.”
Roughly 146,000 people have died from COVID or COVID-related causes in the U.S., according to CDC data.
The most recent publicized federal data records 48,000 deaths from suicide and at least 1.4 million attempts in 2018. In 2019, almost 71,000 people died from drug overdoses.
Where Redfield obtained his data is unknown, although a doctor at John Muir Medical Center in Walnut Creek, CA claimed the facility has “seen a year’s worth of suicide attempts in the last four weeks.” He did not say how many deaths occurred, or whether the statement was exaggerated for emphasis.
“What I have seen recently, I have never seen before,” Hansen said. “I have never seen so much intentional injury,” said a nurse from the same hospital.
And while health authorities will not have verified data regarding suicides and drug overdoses in 2020 for two more years, local reporting indicates that suicide fatalities have increased year-on-year.
According to the American Medical Association, “More than 35 states have reported increases in opioid-related mortality as well as ongoing concerns for those with a mental illness or substance use disorder in counties and other areas within the state.”
In Eagle County, Colorado, six suicides have been recorded, just one below the yearly average. Colorado on the whole recorded a 40 percent decrease in suicides in March and April, but the number of calls to Colorado Crisis Services increased 48 percent.
The Chicago Sun-Times looked specifically at black populations. In Cook County, Illinois, the number of suicide deaths is already higher than for all of 2019.
In Yakima County, Washington, the suicide rate has risen 30 percent, according to the county coroner.
Between March 15 and April 29, as many people commited suicide in Queens, New York than did between January 1 and April 29 the year prior.
The Pima County Health Department in Arizona has recorded an uptick in suicide rates as well.
Ulster County reported a significant increase in both suicides and drug overdoses, both fatal and non-fatal.
Historical trends give reason to believe the suicide rate may rise due to extenuating circumstances caused by COVID-19, including unemployment and social isolation. For example, in the year after the Great Recession in 2008, the rate in America was 6.4 percent higher than expected. While the rate didn’t’ “skyrocket,” as some have predicted it will this year, the coronavirus pandemic and economic shutdown has dealt a worse blow to the U.S. psyche.
Thirty to 40 million jobs have been lost to the economic shutdown, compared to 2.6 million in 2008.
Editor’s Note: This piece has been updated to clarify that the CDC director was referring specifically to high school students when discussing the rate of suicides vs. COVID deaths.


australiannationalreview--2020-07-31--The Global Elite & The Coronavirus Coup D’état With Patrick Wood

The Global Elite & The Coronavirus Coup D ’ état With Patrick Wood .
In this interview , Spiro is @ @ @ @ @ is a leading and critical expert on Sustainable Development , Green Economy , Agenda 21 @ @ @ @ @ Technocracy .
Spiro and Patrick Wood discuss what is technocracy , who are the technocrats @ @ @ @ @ .
The two also analyze how the social engineers have positioned themselves to capitalize upon @ @ @ @ @ their technocratic agenda .

The Global Elite & The Coronavirus Coup D’état With Patrick Wood.
By Spiro Skouras

In this interview, Spiro is joined by Patrick Wood who is a leading and critical expert on Sustainable Development, Green Economy, Agenda 21, 2030 Agenda and historic Technocracy.
Spiro and Patrick Wood discuss what is technocracy, who are the technocrats and what is their agenda.
The two also analyze how the social engineers have positioned themselves to capitalize upon this manufactured crisis to implement their technocratic agenda.


australiannationalreview--2020-07-31--Smart Dust Is Coming. Are You Ready?

Smart Dust Is Coming. Are You Ready?

Smart Dust Is Coming .
Are You Ready ?
Imagine a world where wireless devices are as small as a grain of salt .
These miniaturized devices have sensors , cameras and communication mechanisms to transmit the data they collect back to a base in order to process .
Today , you no longer have to imagine it : microelectromechanical systems ( MEMS ) , often called motes , are real , and they very well could be coming to a neighborhood near you .
Whether this fact excites or strikes fear in you it ’ s good to know @ @ @ @ @ @ @ What can smart dust do ?
Outfitted with miniature sensors , MEMS can detect everything from light to vibrations to temperature .
With an incredible amount of power packed into its small size , MEMS combine sensing , an autonomous power supply , computing and wireless communication in a space that is typically only a few millimeters in volume .
With such a small size , these devices can stay suspended in an environment just like a particle of dust .
They can : • Collect data including acceleration , stress , pressure @ @ @ @ @ @ @ sensors • Process the data with what amounts to an onboard computer system • Wirelessly communicate the data to the cloud , a base or other MEMs Since the components that make up these devices are 3D printed as one piece on a commercially available 3D printer , an incredible amount of complexity can be handled and some previous manufacturing barriers that restricted how small you can make things were overcome .
The optical lenses that are created for these miniaturized sensors can achieve the finest quality images .
The potential of smart @ @ @ @ @ @ @ in incredible detail could impact plenty of things in a variety of industries from safety to compliance to productivity .
It ’ s like multiplying the internet of things technology millions or billions of times over .
Here are just some of the ways it might be used : • Monitor crops in an unprecedented scale to determine watering , fertilization and pest-control needs .
• Enable wireless monitoring of people and products for security purposes .
• Measuring anything that can be measured nearly anywhere .
• Enhance inventory control with MEMS @ @ @ @ @ @ @ to boxes to palettes to shipping vessels to trucks to retail shelves .
• Possible applications for the healthcare industry are immense from diagnostic procedures without surgery to monitoring devices that help people with disabilities interact with tools that help them live independently .
• Researchers at UC Berkeley published a paper about the potential for neural dust , an implantable system to be sprinkled on the human brain , to provide feedback about brain functionality .
There are still plenty of concerns with wide-scale adoption of smart dust that need to be @ @ @ @ @ @ @ disadvantages of smart dust : Many that have reservations about the real-world implications of smart dust are concerned about privacy issues .
Since smart dust devices are miniature sensors they can record anything that they are programmed to record .
Since they are so small , they are difficult to detect .
Your imagination can run wild regarding the negative privacy implications when smart dust falls into the wrong hands .
Once billions of smart dust devices are deployed over an area it would be difficult to retrieve or capture them if necessary @ @ @ @ @ @ @ it would be challenging to detect them if you weren ’ t made aware of their presence .
The volume of smart dust that could be engaged by a rogue individual , company or government to do harm would make it challenging for the authorities to control if necessary .
As with any new technology , the cost to implement a smart dust system that includes the satellites and other elements required for full implementation is high .
Until costs come down , it will be technology out of reach for many .
@ @ @ @ @ @ @ The entities who have led the development of smart dust technology since 1992 and large corporations such as General Electric , Cargill , IBM , Cisco Systems and more who invested in research for smart dust and viable applications believe this technology will be disruptive to economies and our world .
At the moment , many of the applications for smart dust are still in the concept stage .
In fact , Gartner listed smart dust technology for the first time in its Gartner Hype Cycle in 2016 .
While the technology has @ @ @ @ @ @ @ quite a bit to resolve before you will see it impacting your organization .
However , it ’ s important to pay attention to its trajectory of growth , because it ’ s no longer the fodder of science fiction .
We might not know when it will progress to the point of wide-scale adoption , but we certainly know it ’ s a question of when rather than if .

Smart Dust Is Coming. Are You Ready?
By Bernard Marr
Imagine a world where wireless devices are as small as a grain of salt. These miniaturized devices have sensors, cameras and communication mechanisms to transmit the data they collect back to a base in order to process. Today, you no longer have to imagine it: microelectromechanical systems (MEMS), often called motes, are real, and they very well could be coming to a neighborhood near you. Whether this fact excites or strikes fear in you it’s good to know what it’s all about.
What can smart dust do?
Outfitted with miniature sensors, MEMS can detect everything from light to vibrations to temperature. With an incredible amount of power packed into its small size, MEMS combine sensing, an autonomous power supply, computing and wireless communication in a space that is typically only a few millimeters in volume. With such a small size, these devices can stay suspended in an environment just like a particle of dust. They can:
Collect data including acceleration, stress, pressure, humidity, sound and more from sensors
Process the data with what amounts to an onboard computer system
Store the data in memory
Wirelessly communicate the data to the cloud, a base or other MEMs
3D printing on the microscale
Since the components that make up these devices are 3D printed as one piece on a commercially available 3D printer, an incredible amount of complexity can be handled and some previous manufacturing barriers that restricted how small you can make things were overcome. The optical lenses that are created for these miniaturized sensors can achieve the finest quality images.
Practical applications of smart dust
The potential of smart dust to collect information about any environment in incredible detail could impact plenty of things in a variety of industries from safety to compliance to productivity. It’s like multiplying the internet of things technology millions or billions of times over. Here are just some of the ways it might be used:
Monitor crops in an unprecedented scale to determine watering, fertilization and pest-control needs.
Monitor equipment to facilitate more timely maintenance.
Identify weaknesses and corrosion prior to a system failure.
Enable wireless monitoring of people and products for security purposes.
Measuring anything that can be measured nearly anywhere.
Enhance inventory control with MEMS to track products from manufacturing facility shelves to boxes to palettes to shipping vessels to trucks to retail shelves.
Possible applications for the healthcare industry are immense from diagnostic procedures without surgery to monitoring devices that help people with disabilities interact with tools that help them live independently.
Researchers at UC Berkeley published a paper about the potential for neural dust, an implantable system to be sprinkled on the human brain, to provide feedback about brain functionality.
Disadvantages of smart dust
There are still plenty of concerns with wide-scale adoption of smart dust that need to be sorted out. Here are a few disadvantages of smart dust:
Privacy concerns:
Many that have reservations about the real-world implications of smart dust are concerned about privacy issues. Since smart dust devices are miniature sensors they can record anything that they are programmed to record. Since they are so small, they are difficult to detect. Your imagination can run wild regarding the negative privacy implications when smart dust falls into the wrong hands.
Control:
Once billions of smart dust devices are deployed over an area it would be difficult to retrieve or capture them if necessary. Given how small they are, it would be challenging to detect them if you weren’t made aware of their presence. The volume of smart dust that could be engaged by a rogue individual, company or government to do harm would make it challenging for the authorities to control if necessary.
Cost:
As with any new technology, the cost to implement a smart dust system that includes the satellites and other elements required for full implementation is high. Until costs come down, it will be technology out of reach for many.
What should you do to prepare?
The entities who have led the development of smart dust technology since 1992 and large corporations such as General Electric, Cargill, IBM, Cisco Systems and more who invested in research for smart dust and viable applications believe this technology will be disruptive to economies and our world.
At the moment, many of the applications for smart dust are still in the concept stage. In fact, Gartner listed smart dust technology for the first time in its Gartner Hype Cycle in 2016. While the technology has forward momentum, there’s still quite a bit to resolve before you will see it impacting your organization. However, it’s important to pay attention to its trajectory of growth, because it’s no longer the fodder of science fiction. We might not know when it will progress to the point of wide-scale adoption, but we certainly know it’s a question of when rather than if.


australiannationalreview--2020-07-31--Are our conspiracy theory minded friends becoming right more often than wrong?

Are our conspiracy theory minded friends becoming right more often than wrong ?
I THINK YOU MIGHT NEED TO APOLOGISE @ @ @ @ @ ’ FRIENDS… The BBC just published on their travel page that there will be micro-trackers @ @ @ @ @ permanently stay under your skin , funded by Bill Gates Foundation , so we can @ @ @ @ @ for things like Coronavirus… Here is the link to the full article .
They are @ @ @ @ @ these micro-trackers in the Measles v*ccine .
Then will apply to others .
Will you @ @ @ @ @ do you feel about this ?

Are our conspiracy theory minded friends becoming right more often than wrong?
By Luke Scott
I THINK YOU MIGHT NEED TO APOLOGISE TO YOUR ‘CONSPIRACY THEORY’ FRIENDS…
The BBC just published on their travel page that there will be micro-trackers in the upcoming v*ccines that permanently stay under your skin, funded by Bill Gates Foundation, so we can track who has been vaccinated for things like Coronavirus…
Here is the link to the full article.
They are planning to initially start putting these micro-trackers in the Measles v*ccine. Then will apply to others. Will you be getting it?
How do you feel about this?
https://www.bbc.com/…/…/20200621-will-travel-be-safer-by-2022


australiannationalreview--2020-07-31--WHO ARE THE GATES?

WHO ARE THE GATES?

WHO ARE THE GATES ?


australiannationalreview--2020-07-31--TX DOCTOR: Among Physicians Who Believe Hydroxychloroquine Works

TX DOCTOR : Among Physicians Who Believe Hydroxychloroquine Works .


australiannationalreview--2020-07-31--THE BIG TECH CENSORSHIP SCANDAL IS GOING JUST AS VIRAL AS THE BANNED DOCTORS VIDEO!!

THE BIG TECH CENSORSHIP SCANDAL IS GOING JUST AS VIRAL AS THE BANNED DOCTORS VIDEO !
!


australiannationalreview--2020-07-31--How Bill Gates Monopolised Global Health


australiannationalreview--2020-08-01--Vaccine Companies Partner with Mastercard to Merge Vaccines with Cashless Money System

Vaccine Companies Partner with Mastercard to Merge Vaccines with Cashless Money System A partnership between the Bill Gates-backed GAVI vaccine alliance and the biometric ID company , Trust Stamp , will test a digital identity system to be linked to Mastercard ’ s click-to-pay system .
The goal is to eliminate cash .
The program will be introduced in West Africa and will be tied to the COVID-19 vaccine to be made mandatory in 2021 .
Your vaccine status will be updated as you receive more vaccines .
No vaccines ?
No money .
That ’ s the ultimate control @ @ @ @ @ @ @ that “ evolves just as you evolve ” is set to be introduced in “ low-income , remote communities ” in West Africa thanks to a public-private partnership between the Bill Gates-backed GAVI vaccine alliance , Mastercard and the AI-powered “ identity authentication ” company , Trust Stamp .
The program , which was first launched in late 2018 , will see Trust Stamp ’ s digital identity platform integrated into the GAVI-Mastercard “ Wellness Pass , ” a digital vaccination record and identity system that is also linked to Mastercard ’ s @ @ @ @ @ @ @ and machine learning technology called NuData .
Mastercard , in addition to professing its commitment to promoting “ centralized record keeping of childhood immunization ” also describes itself as a leader toward a “ World Beyond Cash , ” and its partnership with GAVI marks a novel approach towards linking a biometric digital identity system , vaccination records , and a payment system into a single cohesive platform .
The effort , since its launch nearly two years ago , has been funded via $ 3.8 million in GAVI donor funds in addition @ @ @ @ @ @ @ amount by the Bill and Melinda Gates Foundation .
In early June , GAVI reported that Mastercard ’ s Wellness Pass program would be adapted in response to the coronavirus ( COVID-19 ) pandemic .
Around a month later , Mastercard announced that Trust Stamp ’ s biometric identity platform would be integrated into Wellness Pass as Trust Stamp ’ s system is capable of providing biometric identity in areas of the world lacking internet access or cellular connectivity and also does not require knowledge of an individual ’ s legal name or @ @ @ @ @ @ @ involving GAVI , Mastercard , and Trust Stamp will soon be launched in West Africa and will be coupled with a Covid-19 vaccination program once a vaccine becomes available .

Vaccine Companies Partner with Mastercard to Merge Vaccines with Cashless Money System
By Mintpress news and Dr. Pam Popper
A partnership between the Bill Gates-backed GAVI vaccine alliance and the biometric ID company, Trust Stamp, will test a digital identity system to be linked to Mastercard’s click-to-pay system. The goal is to eliminate cash. The program will be introduced in West Africa and will be tied to the COVID-19 vaccine to be made mandatory in 2021. Your vaccine status will be updated as you receive more vaccines. No vaccines? No money. That’s the ultimate control. -GEG
Dr. Pam Popper’s website against the Covid-19 vaccine:
www.MakeAmericansFreeAgain.com
A biometric digital identity platform that “evolves just as you evolve” is set to be introduced in “low-income, remote communities” in West Africa thanks to a public-private partnership between the Bill Gates-backed GAVI vaccine alliance, Mastercard and the AI-powered “identity authentication” company, Trust Stamp.
The program, which was first launched in late 2018, will see Trust Stamp’s digital identity platform integrated into the GAVI-Mastercard “Wellness Pass,” a digital vaccination record and identity system that is also linked to Mastercard’s click-to-play system that powered by its AI and machine learning technology called NuData. Mastercard, in addition to professing its commitment to promoting “centralized record keeping of childhood immunization” also describes itself as a leader toward a “World Beyond Cash,” and its partnership with GAVI marks a novel approach towards linking a biometric digital identity system, vaccination records, and a payment system into a single cohesive platform. The effort, since its launch nearly two years ago, has been funded via $3.8 million in GAVI donor funds in addition to a matched donation of the same amount by the Bill and Melinda Gates Foundation.
In early June, GAVI reported that Mastercard’s Wellness Pass program would be adapted in response to the coronavirus (COVID-19) pandemic. Around a month later, Mastercard announced that Trust Stamp’s biometric identity platform would be integrated into Wellness Pass as Trust Stamp’s system is capable of providing biometric identity in areas of the world lacking internet access or cellular connectivity and also does not require knowledge of an individual’s legal name or identity to function. The Wellness Program involving GAVI, Mastercard, and Trust Stamp will soon be launched in West Africa and will be coupled with a Covid-19 vaccination program once a vaccine becomes available.
Read full article here…


australiannationalreview--2020-08-01--Doctors Threatened Over Hydroxychloroquine Use

Watch this !
Before it too is karputed


australiannationalreview--2020-08-01--The Key to Defeating COVID-19 Already Exists. We Need to Start Using It

The Key to Defeating COVID-19 Already Exists .
We Need to Start Using It .
As professor of epidemiology at Yale School of Public Health , I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals .
I am usually accustomed to advocating for positions within the mainstream of medicine , so have been flummoxed to find that , in the midst of a crisis , I am fighting for a treatment that the data fully support but which , for reasons having nothing to do with a correct understanding @ @ @ @ @ @ @ to the sidelines .
As a result , tens of thousands of patients with COVID-19 are dying unnecessarily .
Fortunately , the situation can be reversed easily and quickly .
I am referring , of course , to the medication hydroxychloroquine .
When this inexpensive oral medication is given very early in the course of illness , before the virus has had time to multiply beyond control , it has shown to be highly effective , especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc .
@ @ @ @ @ @ @ article in the American Journal of Epidemiology ( AJE ) entitled , “ Early Outpatient Treatment of Symptomatic , High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.
” That article , published in the world ’ s leading epidemiology journal , analyzed five studies , demonstrating clear-cut and significant benefits to treated patients , plus other very large studies that showed the medication safety .
Physicians who have been using these medications in the face of widespread skepticism have been truly heroic .
They have done what @ @ @ @ @ @ @ patients , often at great personal risk .
I myself know of two doctors who have saved the lives of hundreds of patients with these medications , but are now fighting state medical boards to save their licenses and reputations .
The cases against them are completely without scientific merit .
Since publication of my May 27 article , seven more studies have demonstrated similar benefit .
In a lengthy follow-up letter , also published by AJE , I discuss these seven studies and renew my call for the immediate early use of @ @ @ @ @ @ @ studies include : an additional 400 high-risk patients treated by Dr. Vladimir Zelenko , with zero deaths ; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S. , with no deaths ; a controlled trial of more than 700 high-risk patients in Brazil , with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine ; and another study of 398 matched patients in France , also with significantly reduced hospitalization risk .
Since my letter was published , even more doctors @ @ @ @ @ @ @ use .
My original article in the AJE is available free online , and I encourage readers—especially physicians , nurses , physician assistants and associates , and respiratory therapists—to search the title and read it .
My follow-up letter is linked there to the original paper .
Beyond these studies of individual patients , we have seen what happens in large populations when these drugs are used .
These have been “ natural experiments.
” In the northern Brazil state of Pará , COVID-19 deaths were increasing exponentially .
On April 6 , @ @ @ @ @ @ @ of azithromycin and 90,000 doses of hydroxychloroquine .
Over the next few weeks , authorities began distributing these medications to infected individuals .
Even though new cases continued to occur , on May 22 the death rate started to plummet and is now about one-eighth what it was at the peak .
A reverse natural experiment happened in Switzerland .
On May 27 , the Swiss national government banned outpatient use of hydroxychloroquine for COVID-19 .
Around June 10 , COVID-19 deaths increased four-fold and remained elevated .
On June 11 , the @ @ @ @ @ @ @ on June 23 the death rate reverted to what it had been beforehand .
People who die from COVID-19 live about three to five weeks from the start of symptoms , which makes the evidence of a causal relation in these experiments strong .
Both episodes suggest that a combination of hydroxychloroquine and its companion medications reduces mortality and should be immediately adopted as the new standard of care in high-risk patients .
Why has hydroxychloroquine been disregarded ?
First , as all know , the medication has become highly politicized .
For @ @ @ @ @ @ @ marker of political identity , on both sides of the political spectrum .
Nobody needs me to remind them that this is not how medicine should proceed .
We must judge this medication strictly on the science .
When doctors graduate from medical school , they formally promise to make the health and life of the patient their first consideration , without biases of race , religion , nationality , social standing—or political affiliation .
Lives must come first .
Second , the drug has not been used properly in many studies .
@ @ @ @ @ @ @ early in high-risk people but , as one would expect for an antiviral , much less success when used late in the disease course .
Even so , it has demonstrated significant benefit in large hospital studies in Michigan and New York City when started within the first 24 to 48 hours after admission .
In fact , as inexpensive , oral and widely available medications , and a nutritional supplement , the combination of hydroxychloroquine , azithromycin or doxycycline , and zinc are well-suited for early treatment in the outpatient setting .
@ @ @ @ @ @ @ patients immediately upon clinical suspicion of COVID-19 disease , without waiting for results of testing .
Delays in waiting before starting the medications can reduce their efficacy .
Third , concerns have been raised by the FDA and others about risks of cardiac arrhythmia , especially when hydroxychloroquine is given in combination with azithromycin .
The FDA based its comments on data in its FDA Adverse Event Reporting System .
This reporting system captured up to a thousand cases of arrhythmias attributed to hydroxychloroquine use .
In fact , the number is likely @ @ @ @ @ @ @ system , which requires physicians or patients to initiate contact with the FDA , appreciably undercounts drug side effects .
But what the FDA did not announce is that these adverse events were generated from tens of millions of patient uses of hydroxychloroquine for long periods of time , often for the chronic treatment of lupus or rheumatoid arthritis .
Even if the true rates of arrhythmia are ten-fold higher than those reported , the harms would be minuscule compared to the mortality occurring right now in inadequately treated high-risk COVID-19 patients .
@ @ @ @ @ @ @ University study of more than 320,000 older patients taking both hydroxychloroquine and azithromycin , who had arrhythmia excess death rates of less than 9/100,000 users , as I discuss in my May 27 paper cited above .
A new paper in the American Journal of Medicine by established cardiologists around the world fully agrees with this .
In the future , I believe this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence .
But for now , reality @ @ @ @ @ @ @ the evidence and where it points .
For the sake of high-risk patients , for the sake of our parents and grandparents , for the sake of the unemployed , for our economy and for our polity , especially those disproportionally affected , we must start treating immediately .

The Key to Defeating COVID-19 Already Exists. We Need to Start Using It.
By HARVEY A. RISCH, MD, PhD
As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.” That article, published in the world’s leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.
Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk. I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.
Since publication of my May 27 article, seven more studies have demonstrated similar benefit. In a lengthy follow-up letter, also published by AJE, I discuss these seven studies and renew my call for the immediate early use of hydroxychloroquine in high-risk patients. These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S., with no deaths; a controlled trial of more than 700 high-risk patients in Brazil, with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine; and another study of 398 matched patients in France, also with significantly reduced hospitalization risk. Since my letter was published, even more doctors have reported to me their completely successful use.
My original article in the AJE is available free online, and I encourage readers—especially physicians, nurses, physician assistants and associates, and respiratory therapists—to search the title and read it. My follow-up letter is linked there to the original paper.
Beyond these studies of individual patients, we have seen what happens in large populations when these drugs are used. These have been “natural experiments.” In the northern Brazil state of Pará, COVID-19 deaths were increasing exponentially. On April 6, the public hospital network purchased 75,000 doses of azithromycin and 90,000 doses of hydroxychloroquine. Over the next few weeks, authorities began distributing these medications to infected individuals. Even though new cases continued to occur, on May 22 the death rate started to plummet and is now about one-eighth what it was at the peak.
A reverse natural experiment happened in Switzerland. On May 27, the Swiss national government banned outpatient use of hydroxychloroquine for COVID-19. Around June 10, COVID-19 deaths increased four-fold and remained elevated. On June 11, the Swiss government revoked the ban, and on June 23 the death rate reverted to what it had been beforehand. People who die from COVID-19 live about three to five weeks from the start of symptoms, which makes the evidence of a causal relation in these experiments strong. Both episodes suggest that a combination of hydroxychloroquine and its companion medications reduces mortality and should be immediately adopted as the new standard of care in high-risk patients.
Why has hydroxychloroquine been disregarded?
First, as all know, the medication has become highly politicized. For many, it is viewed as a marker of political identity, on both sides of the political spectrum. Nobody needs me to remind them that this is not how medicine should proceed. We must judge this medication strictly on the science. When doctors graduate from medical school, they formally promise to make the health and life of the patient their first consideration, without biases of race, religion, nationality, social standing—or political affiliation. Lives must come first.
Second, the drug has not been used properly in many studies. Hydroxychloroquine has shown major success when used early in high-risk people but, as one would expect for an antiviral, much less success when used late in the disease course. Even so, it has demonstrated significant benefit in large hospital studies in Michigan and New York City when started within the first 24 to 24 hours after admission.
In fact, as inexpensive, oral and widely available medications, and a nutritional supplement, the combination of hydroxychloroquine, azithromycin or doxycycline, and zinc are well-suited for early treatment in the outpatient setting. The combination should be prescribed in high-risk patients immediately upon clinical suspicion of COVID-19 disease, without waiting for results of testing. Delays in waiting before starting the medications can reduce their efficacy.
Third, concerns have been raised by the FDA and others about risks of cardiac arrhythmia, especially when hydroxychloroquine is given in combination with azithromycin. The FDA based its comments on data in its FDA Adverse Event Reporting System. This reporting system captured up to a thousand cases of arrhythmias attributed to hydroxychloroquine use. In fact, the number is likely higher than that, since the reporting system, which requires physicians or patients to initiate contact with the FDA, appreciably undercounts drug side effects.
But what the FDA did not announce is that these adverse events were generated from tens of millions of patient uses of hydroxychloroquine for long periods of time, often for the chronic treatment of lupus or rheumatoid arthritis. Even if the true rates of arrhythmia are ten-fold higher than those reported, the harms would be minuscule compared to the mortality occurring right now in inadequately treated high-risk COVID-19 patients. This fact is proven by an Oxford University study of more than 320,000 older patients taking both hydroxychloroquine and azithromycin, who had arrhythmia excess death rates of less than 9/100,000 users, as I discuss in my May 27 paper cited above. A new paper in the American Journal of Medicine by established cardiologists around the world fully agrees with this.
In the future, I believe this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence. But for now, reality demands a clear, scientific eye on the evidence and where it points. For the sake of high-risk patients, for the sake of our parents and grandparents, for the sake of the unemployed, for our economy and for our polity, especially those disproportionally affected, we must start treating immediately.


australiannationalreview--2020-08-01--Use hydroxychloroquine combo early, urges Yale professor

Yale Epidemiologist Dr. Harvey Risch is calling for hydroxychloroquine and the antibiotic azithromycin to be made widely available and promoted immediately so physicians can prescribed them for early outpatient COVID-19 treatment .
The Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine has authored a soon-to-be-published article arguing that in an ideal world , randomized double-blinded controlled clinical trials are preferable , but exceptions should be made due to the unprecedented nature of the COVID-19 pandemic .
The article will be published by Oxford University Press @ @ @ @ @ @ @ Bloomberg School of Public Health titled “ Early Outpatient Treatment of Symptomatic , High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.
” “ In this context , we can not afford the luxury of perfect knowledge and must evaluate , now and on an ongoing basis , the evidence for benefit and risk of these medications , ” he urges .
Dr. Risch received his MD degree from the University of California San Diego and PhD from the University of Chicago .
He was a faculty member @ @ @ @ @ @ @ of Toronto before coming to Yale .
He discusses ongoing randomized trials with hydroxychloroquine ( HCQ ) and azithromycin ( AZ ) , arguing , “ For the earliest trial , between now and September , assuming a flat epidemic curve of 10,000 deaths per week , I estimate that approximately 180,000 more deaths will occur in the US before the trial results are known.
” Professor Risch describes various studies in the article , comparing the case fatality rates typically observed without treatment to those with HCQ+AZ treatment .
He points out @ @ @ @ @ @ @ in the remdesivir trials both by Wang et al and in the ACT trials sponsored by the National Institutes of Health ( NIH ) .
Professor Risch also discusses the issue of adverse events , contending that “ the FDA , NIH and cardiology society warnings about cardiac arrhythmia adverse events , while appropriate for theoretical and physiological considerations about use of these medications , are not borne out in mortality in real-world usage of them.
” “ It would therefore be incumbent upon all three organizations to reevaluate their positions as soon @ @ @ @ @ @ @ .
“ Some people will have contraindications and will need other agents for treatment or to remain in isolation .
But for the great majority , I conclude that HCQ+AZ and HCQ+doxycycline , preferably with zinc can be this outpatient treatment , at least until we find or add something better , whether that could be remdesivir or something else , ” he notes .
“ We have a solution , imperfect , to attempt to deal with the disease .
We have to let physicians employing good clinical judgement use it and @ @ @ @ @ @ @ is a small chance that it may not work .
But the urgency demands that we at least start to take that risk and evaluate what happens , and if our situation does not improve we can stop it … ” “ … but we will know that we did everything that we could instead of sitting by and letting hundreds of thousands die because we did not have the courage to act according to our rational calculations , ” Professor Risch concludes .
During a CNN interview on Wednesday , National Institute @ @ @ @ @ @ @ Fauci insisted that hydroxychloroquine lacks “ efficacy ” as a treatment for coronavirus .
A study published in The Lancet last week was “ unable to confirm a benefit of hydroxychloroquine or chloroquine .
.
.
on in-hospital outcomes for COVID-19.
” The study also stated hydroxychloroquine drug regimens were “ associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.
” President Trump has relentlessly promoted the use of at great political risk in order to save lives and reduce the COVID-19 death toll @ @ @ @ @ @ @ he had been taking hydroxychloroquine as a prophylactic for “ a couple of weeks , ” along with zinc and azithromycin .

Use hydroxychloroquine combo early, urges Yale professor.
By Dawn Joseph
Yale Epidemiologist Dr. Harvey Risch is calling for hydroxychloroquine and the antibiotic azithromycin to be made widely available and promoted immediately so physicians can prescribed them for early outpatient COVID-19 treatment.
The Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine has authored a soon-to-be-published article arguing that in an ideal world, randomized double-blinded controlled clinical trials are preferable, but exceptions should be made due to the unprecedented nature of the COVID-19 pandemic.
The article will be published by Oxford University Press, on behalf of the Johns Hopkins Bloomberg School of Public Health titled “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.”
“It is our obligation not to stand by, just “carefully watching,” as the old and infirm and inner city of us are killed by this disease and our economy is destroyed by it and we have nothing to offer except high-mortality hospital treatment.”
“In this context, we cannot afford the luxury of perfect knowledge and must evaluate, now and on an ongoing basis, the evidence for benefit and risk of these medications,” he urges.
Dr. Risch received his MD degree from the University of California San Diego and PhD from the University of Chicago. He was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale.
He discusses ongoing randomized trials with hydroxychloroquine (HCQ) and azithromycin (AZ), arguing, “For the earliest trial, between now and September, assuming a flat epidemic curve of 10,000 deaths per week, I estimate that approximately 180,000 more deaths will occur in the US before the trial results are known.”
“Available evidence of efficacy of HCQ+AZ has been repeatedly described in the media as “anecdotal,” but most certainly is not.”
Professor Risch describes various studies in the article, comparing the case fatality rates typically observed without treatment to those with HCQ+AZ treatment.
He points out the 12-13% mortality of hospitalized patients in the remdesivir trials both by Wang et al and in the ACT trials sponsored by the National Institutes of Health (NIH).
Professor Risch also discusses the issue of adverse events, contending that “the FDA, NIH and cardiology society warnings about cardiac arrhythmia adverse events, while appropriate for theoretical and physiological considerations about use of these medications, are not borne out in mortality in real-world usage of them.”
“It would therefore be incumbent upon all three organizations to reevaluate their positions as soon as possible,” writes Professor Risch.
“Some people will have contraindications and will need other agents for treatment or to remain in isolation. But for the great majority, I conclude that HCQ+AZ and HCQ+doxycycline, preferably with zinc can be this outpatient treatment, at least until we find or add something better, whether that could be remdesivir or something else,” he notes.
“We have a solution, imperfect, to attempt to deal with the disease. We have to let physicians employing good clinical judgement use it and informed patients choose it.”
“There is a small chance that it may not work. But the urgency demands that we at least start to take that risk and evaluate what happens, and if our situation does not improve we can stop it …”
“… but we will know that we did everything that we could instead of sitting by and letting hundreds of thousands die because we did not have the courage to act according to our rational calculations,” Professor Risch concludes.
During a CNN interview on Wednesday, National Institute of Allergy and Infectious Diseases Director Anthony Fauci insisted that hydroxychloroquine lacks “efficacy” as a treatment for coronavirus.
A study published in The Lancet last week was “unable to confirm a benefit of hydroxychloroquine or chloroquine . . . on in-hospital outcomes for COVID-19.”
The study also stated hydroxychloroquine drug regimens were “associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.”
President Trump has relentlessly promoted the use of at great political risk in order to save lives and reduce the COVID-19 death toll.
He even announced last month that he had been taking hydroxychloroquine as a prophylactic for “a couple of weeks,” along with zinc and azithromycin.


australiannationalreview--2020-08-01--Jordan Peterson – Donald Trump’s IQ

Jordan Peterson – Donald Trump’s IQ

By Man Of All Creation Doctor Jordan shares some thoughts on what exactly he believes Trump ’ s IQ to @ @ @ @ @ life accomplishments .


australiannationalreview--2020-08-01--Hydroxychloroquine, a less toxic derivative of chloroquine is effective in inhibiting SARS-CoV-2 inf

Hydroxychloroquine , a less toxic derivative of chloroquine is effective in inhibiting SARS-CoV-2 infection in vitro .
The outbreak of coronavirus disease 2019 ( COVID-19 ) caused by the severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2/2019-nCoV ) poses a serious threat to global public health and local economies .
As of March 3 , 2020 , over 80,000 cases have been confirmed in China , including 2946 deaths as well as over 10,566 confirmed cases in 72 other countries .
Such huge numbers of infected and dead people call for an urgent demand of effective , available , and @ @ @ @ @ @ @ epidemic .
We have recently reported that two drugs , remdesivir ( GS-5734 ) and chloroquine ( CQ ) phosphate , efficiently inhibited SARS-CoV-2 infection in vitro1 .
Remdesivir is a nucleoside analog prodrug developed by Gilead Sciences ( USA ) .
A recent case report showed that treatment with remdesivir improved the clinical condition of the first patient infected by SARS-CoV-2 in the United States2 , and a phase III clinical trial of remdesivir against SARS-CoV-2 was launched in Wuhan on February 4 , 2020 .
However , as an experimental drug @ @ @ @ @ @ @ largely available for treating a very large number of patients in a timely manner .
Therefore , of the two potential drugs , CQ appears to be the drug of choice for large-scale use due to its availability , proven safety record , and a relatively low cost .
In light of the preliminary clinical data , CQ has been added to the list of trial drugs in the Guidelines for the Diagnosis and Treatment of COVID-19 ( sixth edition ) published by National Health Commission of the People ’ s Republic of @ @ @ @ @ @ @ ) -N1 , N1-diethyl-1,4-pentanediamine ) has long been used to treat malaria and amebiasis .
However , Plasmodium falciparum developed widespread resistance to it , and with the development of new antimalarials , it has become a choice for the prophylaxis of malaria .
In addition , an overdose of CQ can cause acute poisoning and death3 .
In the past years , due to infrequent utilization of CQ in clinical practice , its production and market supply was greatly reduced , at least in China .
Hydroxychloroquine ( HCQ ) sulfate , @ @ @ @ @ @ @ synthesized in 1946 by introducing a hydroxyl group into CQ and was demonstrated to be much less ( ~40 % ) toxic than CQ in animals4 .
More importantly , HCQ is still widely available to treat autoimmune diseases , such as systemic lupus erythematosus and rheumatoid arthritis .
Since CQ and HCQ share similar chemical structures and mechanisms of acting as a weak base and immunomodulator , it is easy to conjure up the idea that HCQ may be a potent candidate to treat infection by SARS-CoV-2 .
Actually , as of @ @ @ @ @ @ @ trial registries were found in Chinese Clinical Trial Registry ( http : //www.chictr.org.cn ) for using HCQ to treat COVID-19 .
Whether HCQ is as efficacious as CQ in treating SARS-CoV-2 infection still lacks the experimental evidence .
To this end , we evaluated the antiviral effect of HCQ against SARS-CoV-2 infection in comparison to CQ in vitro .
First , the cytotoxicity of HCQ and CQ in African green monkey kidney VeroE6 cells ( ATCC-1586 ) was measured by standard CCK8 assay , and the result showed that the 50 % cytotoxic @ @ @ @ @ @ @ and HCQ were 273.20 and 249.50 μM , respectively , which are not significantly different from each other ( Fig .
 1a ) .
To better compare the antiviral activity of CQ versus HCQ , the dose–response curves of the two compounds against SARS-CoV-2 were determined at four different multiplicities of infection ( MOIs ) by quantification of viral RNA copy numbers in the cell supernatant at 48 h post infection ( p.i. )
.
The data summarized in Fig .
 1a and Supplementary Table S1 show that , at all @ @ @ @ @ @ @ , and 0.8 ) , the 50 % maximal effective concentration ( EC ) for CQ ( 2.71 , 3.81 , 7.14 , and 7.36 μM ) was lower than that of HCQ ( 4.51 , 4.06 , 17.31 , and 12.96 μM ) .
The differences in EC values were statistically significant at an MOI of 0.01 ( P < 0.05 ) and MOI of 0.2 ( P < 0.001 ) ( Supplementary Table S1 ) .
It is worth noting that the EC values of CQ seemed to be a little @ @ @ @ @ @ @ ( 1.13 μM at an MOI of 0.05 ) 1 , which is likely due to the adaptation of the virus in cell culture that significantly increased viral infectivity upon continuous passaging .
Consequently , the selectivity index ( SI = CC /EC ) of CQ ( 100.81 , 71.71 , 38.26 , and 37.12 ) was higher than that of HCQ ( 55.32 , 61.45 , 14.41 , 19.25 ) at MOIs of 0.01 , 0.02 , 0.2 , and 0.8 , respectively .
These results were corroborated by immunofluorescence microscopy as @ @ @ @ @ @ @ nucleoprotein ( NP ) at the indicated drug concentrations at 48 h p.i .
( Supplementary Fig .
S1 ) .
Taken together , the data suggest that the anti-SARS-CoV-2 activity of HCQ seems to be less potent compared to CQ , at least at certain MOIs .
Both CQ and HCQ are weak bases that are known to elevate the pH of acidic intracellular organelles , such as endosomes/lysosomes , essential for membrane fusion5 .
In addition , CQ could inhibit SARS-CoV entry through changing the glycosylation of ACE2 receptor and spike @ @ @ @ @ @ @ effectively inhibited the entry step , as well as the post-entry stages of SARS-CoV-2 , which was also found upon CQ treatment ( Supplementary Fig .
S2 ) .
To further explore the detailed mechanism of action of CQ and HCQ in inhibiting virus entry , co-localization of virions with early endosomes ( EEs ) or endolysosomes ( ELs ) was analyzed by immunofluorescence analysis ( IFA ) and confocal microscopy .
Quantification analysis showed that , at 90 min p.i .
in untreated cells , 16.2 % of internalized virions ( anti-NP @ @ @ @ @ @ @ endosome antigen 1 ( EEA1 ) -positive EEs ( green ) , while more virions ( 34.3 % ) were transported into the late endosomal–lysosomal protein LAMP1+ ELs ( green ) ( n > 30 cells for each group ) .
By contrast , in the presence of CQ or HCQ , significantly more virions ( 35.3 % for CQ and 29.2 % for HCQ ; P < 0.001 ) were detected in the EEs , while only very few virions ( 2.4 % for CQ and 0.03 % for HCQ ; P @ @ @ @ @ @ @ co-localized with LAMP1+ ELs ( n > 30 cells ) ( Fig . )
.
This suggested that both CQ and HCQ blocked the transport of SARS-CoV-2 from EEs to ELs , which appears to be a requirement to release the viral genome as in the case of SARS-CoV7 .
Interestingly , we found that CQ and HCQ treatment caused noticeable changes in the number and size/morphology of EEs and ELs ( Fig .
 1c ) .
In the untreated cells , most EEs were much smaller than ELs ( Fig .
@ @ @ @ @ @ @ HCQ-treated cells , abnormally enlarged EE vesicles were observed ( Fig .
 1c , arrows in the upper panels ) , many of which are even larger than ELs in the untreated cells .
This is in agreement with previous report that treatment with CQ induced the formation of expanded cytoplasmic vesicles8 .
Within the EE vesicles , virions ( red ) were localized around the membrane ( green ) of the vesicle .
CQ treatment did not cause obvious changes in the number and size of ELs ; however , the @ @ @ @ @ @ @ , at least partially .
By contrast , in HCQ-treated cells , the size and number of ELs increased significantly ( Fig .
 1c , arrows in the lower panels ) .
Since acidification is crucial for endosome maturation and function , we surmise that endosome maturation might be blocked at intermediate stages of endocytosis , resulting in failure of further transport of virions to the ultimate releasing site .
CQ was reported to elevate the pH of lysosome from about 4.5 to 6.5 at 100 μM9 .
To our knowledge , @ @ @ @ @ @ @ the impact of HCQ on the morphology and pH values of endosomes/lysosomes .
Our observations suggested that the mode of actions of CQ and HCQ appear to be distinct in certain aspects .
It has been reported that oral absorption of CQ and HCQ in humans is very efficient .
In animals , both drugs share similar tissue distribution patterns , with high concentrations in the liver , spleen , kidney , and lung reaching levels of 200–700 times higher than those in the plasma10 .
It was reported that safe dosage ( @ @ @ @ @ @ @ sulfate could generate serum levels of 1.4–1.5 μM in humans11 .
Therefore , with a safe dosage , HCQ concentration in the above tissues is likely to be achieved to inhibit SARS-CoV-2 infection .
Clinical investigation found that high concentration of cytokines were detected in the plasma of critically ill patients infected with SARS-CoV-2 , suggesting that cytokine storm was associated with disease severity12 .
Other than its direct antiviral activity , HCQ is a safe and successful anti-inflammatory agent that has been used extensively in autoimmune diseases and can significantly decrease the @ @ @ @ @ @ @ , pro-inflammatory factors .
Therefore , in COVID-19 patients , HCQ may also contribute to attenuating the inflammatory response .
In conclusion , our results show that HCQ can efficiently inhibit SARS-CoV-2 infection in vitro .
In combination with its anti-inflammatory function , we predict that the drug has a good potential to combat the disease .
This possibility awaits confirmation by clinical trials .
We need to point out , although HCQ is less toxic than CQ , prolonged and overdose usage can still cause poisoning .
And the relatively low SI @ @ @ @ @ @ @ of clinical trials to achieve efficient and safe control of the SARS-CoV-2 infection .

Hydroxychloroquine, a less toxic derivative of chloroquine is effective in inhibiting SARS-CoV-2 infection in vitro.
By Cell Discovery
Dear Editor,
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) poses a serious threat to global public health and local economies. As of March 3, 2020, over 80,000 cases have been confirmed in China, including 2946 deaths as well as over 10,566 confirmed cases in 72 other countries. Such huge numbers of infected and dead people call for an urgent demand of effective, available, and affordable drugs to control and diminish the epidemic.
We have recently reported that two drugs, remdesivir (GS-5734) and chloroquine (CQ) phosphate, efficiently inhibited SARS-CoV-2 infection in vitro1. Remdesivir is a nucleoside analog prodrug developed by Gilead Sciences (USA). A recent case report showed that treatment with remdesivir improved the clinical condition of the first patient infected by SARS-CoV-2 in the United States2, and a phase III clinical trial of remdesivir against SARS-CoV-2 was launched in Wuhan on February 4, 2020. However, as an experimental drug, remdesivir is not expected to be largely available for treating a very large number of patients in a timely manner. Therefore, of the two potential drugs, CQ appears to be the drug of choice for large-scale use due to its availability, proven safety record, and a relatively low cost. In light of the preliminary clinical data, CQ has been added to the list of trial drugs in the Guidelines for the Diagnosis and Treatment of COVID-19 (sixth edition) published by National Health Commission of the People’s Republic of China.
CQ (N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine) has long been used to treat malaria and amebiasis. However, Plasmodium falciparum developed widespread resistance to it, and with the development of new antimalarials, it has become a choice for the prophylaxis of malaria. In addition, an overdose of CQ can cause acute poisoning and death3. In the past years, due to infrequent utilization of CQ in clinical practice, its production and market supply was greatly reduced, at least in China. Hydroxychloroquine (HCQ) sulfate, a derivative of CQ, was first synthesized in 1946 by introducing a hydroxyl group into CQ and was demonstrated to be much less (~40%) toxic than CQ in animals4. More importantly, HCQ is still widely available to treat autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. Since CQ and HCQ share similar chemical structures and mechanisms of acting as a weak base and immunomodulator, it is easy to conjure up the idea that HCQ may be a potent candidate to treat infection by SARS-CoV-2. Actually, as of February 23, 2020, seven clinical trial registries were found in Chinese Clinical Trial Registry (https://www.chictr.org.cn) for using HCQ to treat COVID-19. Whether HCQ is as efficacious as CQ in treating SARS-CoV-2 infection still lacks the experimental evidence.
To this end, we evaluated the antiviral effect of HCQ against SARS-CoV-2 infection in comparison to CQ in vitro. First, the cytotoxicity of HCQ and CQ in African green monkey kidney VeroE6 cells (ATCC-1586) was measured by standard CCK8 assay, and the result showed that the 50% cytotoxic concentration (CC 50 ) values of CQ and HCQ were 273.20 and 249.50 μM, respectively, which are not significantly different from each other (Fig.  1a). To better compare the antiviral activity of CQ versus HCQ, the dose–response curves of the two compounds against SARS-CoV-2 were determined at four different multiplicities of infection (MOIs) by quantification of viral RNA copy numbers in the cell supernatant at 48 h post infection (p.i.). The data summarized in Fig.  1a and Supplementary Table S1 show that, at all MOIs (0.01, 0.02, 0.2, and 0.8), the 50% maximal effective concentration (EC 50 ) for CQ (2.71, 3.81, 7.14, and 7.36 μM) was lower than that of HCQ (4.51, 4.06, 17.31, and 12.96 μM). The differences in EC 50 values were statistically significant at an MOI of 0.01 (P < 0.05) and MOI of 0.2 (P < 0.001) (Supplementary Table S1). It is worth noting that the EC 50 values of CQ seemed to be a little higher than that in our previous report (1.13 μM at an MOI of 0.05)1, which is likely due to the adaptation of the virus in cell culture that significantly increased viral infectivity upon continuous passaging. Consequently, the selectivity index (SI = CC 50 /EC 50 ) of CQ (100.81, 71.71, 38.26, and 37.12) was higher than that of HCQ (55.32, 61.45, 14.41, 19.25) at MOIs of 0.01, 0.02, 0.2, and 0.8, respectively. These results were corroborated by immunofluorescence microscopy as evidenced by different expression levels of virus nucleoprotein (NP) at the indicated drug concentrations at 48 h p.i. (Supplementary Fig. S1). Taken together, the data suggest that the anti-SARS-CoV-2 activity of HCQ seems to be less potent compared to CQ, at least at certain MOIs.
Both CQ and HCQ are weak bases that are known to elevate the pH of acidic intracellular organelles, such as endosomes/lysosomes, essential for membrane fusion5. In addition, CQ could inhibit SARS-CoV entry through changing the glycosylation of ACE2 receptor and spike protein6. Time-of-addition experiment confirmed that HCQ effectively inhibited the entry step, as well as the post-entry stages of SARS-CoV-2, which was also found upon CQ treatment (Supplementary Fig. S2). To further explore the detailed mechanism of action of CQ and HCQ in inhibiting virus entry, co-localization of virions with early endosomes (EEs) or endolysosomes (ELs) was analyzed by immunofluorescence analysis (IFA) and confocal microscopy. Quantification analysis showed that, at 90 min p.i. in untreated cells, 16.2% of internalized virions (anti-NP, red) were observed in early endosome antigen 1 (EEA1)-positive EEs (green), while more virions (34.3%) were transported into the late endosomal–lysosomal protein LAMP1+ ELs (green) (n > 30 cells for each group). By contrast, in the presence of CQ or HCQ, significantly more virions (35.3% for CQ and 29.2% for HCQ; P < 0.001) were detected in the EEs, while only very few virions (2.4% for CQ and 0.03% for HCQ; P < 0.001) were found to be co-localized with LAMP1+ ELs (n > 30 cells) (Fig. ). This suggested that both CQ and HCQ blocked the transport of SARS-CoV-2 from EEs to ELs, which appears to be a requirement to release the viral genome as in the case of SARS-CoV7.
Interestingly, we found that CQ and HCQ treatment caused noticeable changes in the number and size/morphology of EEs and ELs (Fig.  1c). In the untreated cells, most EEs were much smaller than ELs (Fig.  1c). In CQ- and HCQ-treated cells, abnormally enlarged EE vesicles were observed (Fig.  1c, arrows in the upper panels), many of which are even larger than ELs in the untreated cells. This is in agreement with previous report that treatment with CQ induced the formation of expanded cytoplasmic vesicles8. Within the EE vesicles, virions (red) were localized around the membrane (green) of the vesicle. CQ treatment did not cause obvious changes in the number and size of ELs; however, the regular vesicle structure seemed to be disrupted, at least partially. By contrast, in HCQ-treated cells, the size and number of ELs increased significantly (Fig.  1c, arrows in the lower panels).
Since acidification is crucial for endosome maturation and function, we surmise that endosome maturation might be blocked at intermediate stages of endocytosis, resulting in failure of further transport of virions to the ultimate releasing site. CQ was reported to elevate the pH of lysosome from about 4.5 to 6.5 at 100 μM9. To our knowledge, there is a lack of studies on the impact of HCQ on the morphology and pH values of endosomes/lysosomes. Our observations suggested that the mode of actions of CQ and HCQ appear to be distinct in certain aspects.
It has been reported that oral absorption of CQ and HCQ in humans is very efficient. In animals, both drugs share similar tissue distribution patterns, with high concentrations in the liver, spleen, kidney, and lung reaching levels of 200–700 times higher than those in the plasma10. It was reported that safe dosage (6–6.5 mg/kg per day) of HCQ sulfate could generate serum levels of 1.4–1.5 μM in humans11. Therefore, with a safe dosage, HCQ concentration in the above tissues is likely to be achieved to inhibit SARS-CoV-2 infection.
Clinical investigation found that high concentration of cytokines were detected in the plasma of critically ill patients infected with SARS-CoV-2, suggesting that cytokine storm was associated with disease severity12. Other than its direct antiviral activity, HCQ is a safe and successful anti-inflammatory agent that has been used extensively in autoimmune diseases and can significantly decrease the production of cytokines and, in particular, pro-inflammatory factors. Therefore, in COVID-19 patients, HCQ may also contribute to attenuating the inflammatory response. In conclusion, our results show that HCQ can efficiently inhibit SARS-CoV-2 infection in vitro. In combination with its anti-inflammatory function, we predict that the drug has a good potential to combat the disease. This possibility awaits confirmation by clinical trials. We need to point out, although HCQ is less toxic than CQ, prolonged and overdose usage can still cause poisoning. And the relatively low SI of HCQ requires careful designing and conducting of clinical trials to achieve efficient and safe control of the SARS-CoV-2 infection.


australiannationalreview--2020-08-01--FAKE NEWS. How accurate are the main stream media sources and facts?

FAKE NEWS .
How accurate are the main stream media sources and facts ?
My mate is a professor at the Alfred and has said , the records the news is sharing are not the same as many hospitals all over VIC , and the government is paying doctors to stay quiet and to not speak up about the huge difference in actual numbers and facts , and what the news and media is reporting and programming the public with .
We are in lockdown and wearing masks etc .
Why is this happening ?
Why are the “ SO-CALLED @ @ @ @ @ @ @ and faster than the first wave ?
Ask yourself this ?
They are leading us all down the rabbit hole .
More test showing that people have “ A VIRUS ” a common virus and cold which is “ NOT ” deadly to a healthy human , which had been the case for hundreds of years .
If you focus on the pole , you will hit the pole .
The elderly are dying from common viruses , personal health challenges , and natural causes .
If this was an epidemic , every @ @ @ @ @ @ @ from the so-called deadly “ Coronavirus ” .

FAKE NEWS. How accurate are the main stream media sources and facts?
By Leigh Bundy
My mate is a professor at the Alfred and has said, the records the news is sharing are not the same as many hospitals all over VIC, and the government is paying doctors to stay quiet and to not speak up about the huge difference in actual numbers and facts, and what the news and media is reporting and programming the public with.
We are in lockdown and wearing masks etc.
Why is this happening?
Why are the “SO-CALLED” numbers still rising, even higher and faster than the first wave?
Ask yourself this?
They are leading us all down the rabbit hole.
More test showing that people have “A VIRUS” a common virus and cold which is “NOT” deadly to a healthy human, which had been the case for hundreds of years.
If you focus on the pole, you will hit the pole.
The elderly are dying from common viruses, personal health challenges, and natural causes.
If this was an epidemic, every person who tested positive would be dead from the so-called deadly “Coronavirus”.


australiannationalreview--2020-08-01--The Victorian Government Bans the most effective treatment of the Coronavirus’ and follows the Clint

The Victorian Government Bans the most effective treatment of the Coronavirus’ and follows the Clinton Soros playbook to boost Coronavirus falsified cases

The Victorian Government Bans the most effective treatment of the Coronavirus ’ and follows the Clinton Soros playbook to boost @ @ @ @


australiannationalreview--2020-08-01--The Inventor Kary Mullis, of method used to test for COVID-19 said it can’t be used in virus detecti

The Inventor Kary Mullis , of method used to test for COVID-19 said it can ’ t be used in virus detection .
Social media users have been sharing a quote attributed to the inventor of the Polymerase Chain Reaction ( PCR ) test , currently being used to detect COVID-19 , which says “ PCR tests can not detect free infectious viruses at all ” .
This quote has been attributed to the inventor , Kary Mullis , and has been taken out of context to falsify its original meaning .
“ COVID-19 TEST a FRAUD ?
” , @ @ @ @ @ @ @ in 1985 and was recognized for this achievement by being awarded the Nobel Prize in Chemistry in 1993 The context around the quote shows Lauritsen is not saying PCR tests do not work .
Instead , he is clarifying that PCR identifies substances qualitatively not quantitatively , detecting the genetic sequences of viruses , but not the viruses themselves : “ PCR is intended to identify substances qualitatively , but by its very nature is unsuited for estimating numbers .
Although there is a common misimpression that the viral load tests actually count @ @ @ @ @ @ @ , these tests can not detect free , infectious viruses at all ; they can only detect proteins that are believed , in some cases wrongly , to be unique to HIV .
The tests can detect genetic sequences of viruses , but not viruses themselves.
” The PCR test is the preferred COVID-19 testing method .
They say it detects the presence of the virus by amplifying the virus ‘ genetic material to a point where it can be detected by scientists .
“ It is important to note that detecting viral @ @ @ @ @ @ @ the virus is fully intact and infectious , i.e .
able to cause infection in other people .
The isolation of infectious virus from positive individuals requires virus culture methods .
These methods can only be conducted in laboratories with specialist containment facilities and are time-consuming and complex.
” PCR tests are being used widely used and are delivering consistent false positives .

The Inventor Kary Mullis, of method used to test for COVID-19 said it can’t be used in virus detection.
By Staff Reporter
Social media users have been sharing a quote attributed to the inventor of the Polymerase Chain Reaction (PCR) test, currently being used to detect COVID-19, which says “PCR tests cannot detect free infectious viruses at all”. This quote has been attributed to the inventor, Kary Mullis, and has been taken out of context to falsify its original meaning.
“COVID-19 TEST a FRAUD?”, Mullis, who invented the PCR method in 1985 and was recognized for this achievement by being awarded the Nobel Prize in Chemistry in 1993
The context around the quote shows Lauritsen is not saying PCR tests do not work. Instead, he is clarifying that PCR identifies substances qualitatively not quantitatively, detecting the genetic sequences of viruses, but not the viruses themselves: “PCR is intended to identify substances qualitatively, but by its very nature is unsuited for estimating numbers. Although there is a common misimpression that the viral load tests actually count the number of viruses in the blood, these tests cannot detect free, infectious viruses at all; they can only detect proteins that are believed, in some cases wrongly, to be unique to HIV. The tests can detect genetic sequences of viruses, but not viruses themselves.”
The PCR test is the preferred COVID-19 testing method. They say it detects the presence of the virus by amplifying the virus ‘genetic material to a point where it can be detected by scientists.
“It is important to note that detecting viral material by PCR does not indicate that the virus is fully intact and infectious, i.e. able to cause infection in other people. The isolation of infectious virus from positive individuals requires virus culture methods. These methods can only be conducted in laboratories with specialist containment facilities and are time-consuming and complex.”
PCR tests are being used widely used and are delivering consistent false positives.


australiannationalreview--2020-08-01--Dr. Fauci knew way back in 2005 Hyrdrixychloroquine was a miracle treatment for SARS Corona Virus in

Dr. Fauci knew way back in 2005 Hyrdrixychloroquine was a miracle treatment for SARS Corona Virus infection .


australiannationalreview--2020-08-01--SECOND OPINION: Doctors Discuss the Politicization of Hydroxychloroquine

SECOND OPINION : Doctors Discuss the Politicization of Hydroxychloroquine .
Dr. Simone Gold and Dr. Dan Wohlgelernter discuss the demonization @ @ @ @ @ Studies set up to fail , murder investigations , and more !


australiannationalreview--2020-08-01--Let’s all do our bit to expose child  sex trafficking

Let ’ s all do our bit to expose child sex trafficking .
This TIKTOK Challenge Took A Very Real @ @ @ @ @ TRAFFICKING